DocGo Inc. (DCGO) Fair Value 2026

DCGO · Services-Health Services ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.2 /10

32 fundamental signals · 9 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-07-15, DocGo Inc. (DCGO) trades at $0.66, approximately 132% above CirclFi’s Bayesian DCF fair value of $0.29. QOC: 4.2/10. Value Trap Risk: 12/100 (SAFE). 9/13 models active.

Key Facts

Ticker
DCGO
Price
$0.66
Quality Score
4.2/10
Value Trap Risk
12/100
Models Active
9/13
Last Updated
Strength: CUCE Ensemble suggests +280.0% upside with 6% confidence
Risk: Below-average Quality Score of 4.2/10 signals weak fundamentals

Is DocGo Inc. (DCGO) Undervalued or Overvalued in 2026?

According to CirclFi’s 9-model valuation engine, DocGo Inc. (DCGO) appears undervalued as of : the median of 9 independent fair value estimates is $1.68, 152.3% above the current price of $0.66. Estimates range from $0.29 to $3.03. DCGO scores 4.2/10 on fundamental quality and 12/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy DocGo Inc. Stock in 2026? →

Valuation Matrix

9 Intrinsic Value Models vs. Current Price ($0.66)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
 $0.29 -57.0%
CUCE Ensemble
Low Conviction
 $2.53 +280.0%
First Chicago
Low Conviction
 $0.90 +35.8%
ML-RIV
High Conviction
 $1.68 +152.3%

Unlock the Full Matrix

Access 5 additional models including EROIC Spread, Dynamic NAV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is DocGo Inc. (DCGO) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for DocGo Inc.. Trading at $0.66 against an estimated intrinsic value of $1.58, 7 of 9 active models flag meaningful upside of +138.4% on average. The most optimistic model, EROIC, places fair value at $3.03 (+355.0%), while Bayesian DCF — the most conservative — estimates $0.29 (-57.0%). This +412.0% gap reflects genuine analytical uncertainty about DocGo Inc.'s intrinsic worth.

What Do the Models Say About DCGO?

9 of 13 models are currently active for DCGO. Of these, 7 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates DCGO's intrinsic value at $0.29, implying -57.0% downside from the current price. See which stocks rank higher →

How Does DCGO Rank in Services-Health Services?

Among 14 Services-Health Services stocks, DCGO ranks #12 by Quality of Company score. CirclFi's QOC score of 4.2/10 evaluates 32 fundamental signals. A score of 4.2 reflects mixed fundamentals.

DocGo Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is DCGO a Value Trap?

CirclFi's Value Trap algorithm assigns DCGO a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for DocGo Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, DocGo Inc.'s fundamental quality profile registers 4.2/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +412.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every DCGO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across DCGO's 9 active models, average confidence is 35%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy DocGo Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Health Services Stocks Should You Also Analyze?

8 related Services-Health Services stocks with 13-model coverage

PNTGThe Pennant Group, Inc.QOC 9.2PRVAPrivia Health Group, Inc.QOC 8.3USPHU.S. Physical Therapy, Inc.QOC 8.0INNVInnovAge Holding Corp.QOC 6.7LFSTLifeStance Health Group, Inc.QOC 6.7TALKTalkspace, Inc.QOC 6.6WGSGeneDx Holdings Corp.QOC 6.1OMDAOmada Health, Inc.QOC 6.0

Read investment analysis: PNTG · PRVA · USPH · INNV · LFST

Frequently Asked Questions About DocGo Inc.

What is DocGo Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, DocGo Inc. (DCGO) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.29. The Quality of Company score is 4.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is DCGO overvalued or undervalued right now?

At $0.66, 7 of 9 active models suggest DCGO may be undervalued, while 2 indicate potential overvaluation. The median of all 9 fair value estimates is $1.68, 152.3% above the current price of $0.66 — a consensus view that DCGO is undervalued. The assessment depends on which methodology best fits DocGo Inc.'s business model in Services-Health Services.

What does a Quality of Company score of 4.2 mean for DCGO?

DocGo Inc.'s QOC of 4.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on DCGO?

CirclFi analyzes DCGO with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Is DCGO a value trap in 2026?

DocGo Inc.'s Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 9-model valuation engine, DocGo Inc. (DCGO) has a median fair value of $1.68 — 152.3% above the current price of $0.66 — as of 2026-07-15.” Source: circlfi.com/stock/DCGO/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on DCGO.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access